http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1857107-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be3928f66bb2545a8175c61c56146b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36a160c3ad2cfc54eee7b6700dfd48e7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
filingDate 2006-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b7011b75dc27cfb3c37ff2dc13c043d
publicationDate 2009-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1857107-A4
titleOfInvention PREVENTIVE OR THERAPEUTIC AGENT FOR CARDIAC DYSFUNCTION OR MYOCARDIAL DAMAGE CAUSED BY ISCHEMIA OR REPERFUSION OF ISCHEMIA
abstract [PROBLEMS] It is intended to provide a preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion that exerts efficacy by a mechanism of action different from a conventional therapeutic agent and can be taken for a long period of time. [MEANS FOR SOLVING PROBLEMS] The invention is directed to a preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion comprises 6-fluoro-2',5'-dioxospiro[chroman-4,4'- imidazolidine]-2-carboxamide, particularly, fidarestat, as an active ingredient. Examples of the cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion include ischemia-reperfusion arrhythmia, cardiac event, cardiac death and the like.
priorityDate 2005-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1064969-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449156
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227452610

Total number of triples: 30.